• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分枝杆菌尿苷二磷酸半乳呋喃糖-吡喃半乳糖变位酶潜在抑制剂的鉴定:一种通过计算机模拟方法确定的新型药物靶点。

Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach.

作者信息

Nayak Tapaswini, Jena Lingaraja, Waghmare Pranita, Harinath Bhaskar C

机构信息

Bioinformatics Centre, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India.

Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India.

出版信息

Int J Mycobacteriol. 2018 Jan-Mar;7(1):61-68. doi: 10.4103/ijmy.ijmy_174_17.

DOI:10.4103/ijmy.ijmy_174_17
PMID:29516888
Abstract

BACKGROUND

The Mycobacterium tuberculosis (MTB) uridine diphosphogalactofuranose (UDP)-galactopyranose mutase (UGM) is an essential flavoenzyme for mycobacterial viability and an important component of cell wall. It catalyzes the interconversion of UDP-galactopyranose into UDP-galactofuranose, a key building block for cell wall construction, essential for linking the peptidoglycan and mycolic acid cell wall layers in MTB through a 2-keto intermediate. Further, as this enzyme is not present in humans, it is an excellent therapeutic target for MTB. Thus, inhibition of this UGM enzyme is a good approach to explore new anti-TB drug. This study aims to find novel and effective inhibitors against UGM from reported natural phytochemicals and ZINC database using virtual screening approach.

METHODS

In this study, 148 phytochemicals with reported antitubercular activity and 5280 ZINC compounds with 70% structural similarity with the natural substrate of UGM (UDP-galactopyranose and UDP-galactofuranose) were screened against UGM.

RESULTS

In virtual screening, 19 phytochemicals and 477 ZINC compounds showed comparatively better binding affinity than natural substrates. Among them, best 10 compounds from each group were proposed as potential inhibitors for UGM based on the binding energy and protein-ligand interaction analysis. Among phytochemicals, three compounds, namely, tiliacorine, amentoflavone, and 2'-nortiliacorinine showed highest binding affinity (binding energy of -10.5, -10.4, and -10.3 Kcal/mol, respectively), while among ZINC compounds, ZINC08219848 and ZINC08217649, showing highest binding affinity (binding energy of -10.0 and -9.7 Kcal/mol, respectively) toward UGM as compared to its substrates.

CONCLUSION

These selected compounds may be proposed as potential inhibitors of UGM and need to be tested in TB culture studies in vitro to assess their anti-TB activity.

摘要

背景

结核分枝杆菌(MTB)的尿苷二磷酸半乳糖呋喃糖(UDP)-吡喃半乳糖变位酶(UGM)是一种对分枝杆菌生存至关重要的黄素酶,也是细胞壁的重要组成部分。它催化UDP-吡喃半乳糖转化为UDP-半乳糖呋喃糖,后者是细胞壁构建的关键组成部分,对于通过2-酮中间体连接MTB中的肽聚糖和分枝菌酸细胞壁层至关重要。此外,由于该酶在人类中不存在,它是MTB的一个极佳治疗靶点。因此,抑制这种UGM酶是探索新型抗结核药物的一个好方法。本研究旨在使用虚拟筛选方法从已报道的天然植物化学物质和ZINC数据库中寻找针对UGM的新型有效抑制剂。

方法

在本研究中,针对UGM筛选了148种具有已报道抗结核活性的植物化学物质和5280种与UGM天然底物(UDP-吡喃半乳糖和UDP-半乳糖呋喃糖)具有70%结构相似性的ZINC化合物。

结果

在虚拟筛选中,19种植物化学物质和477种ZINC化合物显示出比天然底物更好的结合亲和力。其中,基于结合能和蛋白质-配体相互作用分析,每组中最佳的10种化合物被提议作为UGM的潜在抑制剂。在植物化学物质中,三种化合物,即蒂巴因、穗花杉双黄酮和2'-去甲蒂巴因显示出最高的结合亲和力(结合能分别为-10.5、-10.4和-10.3千卡/摩尔),而在ZINC化合物中,ZINC08219848和ZINC08217649与底物相比,对UGM显示出最高的结合亲和力(结合能分别为-10.0和-9.7千卡/摩尔)。

结论

这些选定的化合物可能被提议作为UGM的潜在抑制剂,需要在体外结核培养研究中进行测试,以评估它们的抗结核活性。

相似文献

1
Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach.分枝杆菌尿苷二磷酸半乳呋喃糖-吡喃半乳糖变位酶潜在抑制剂的鉴定:一种通过计算机模拟方法确定的新型药物靶点。
Int J Mycobacteriol. 2018 Jan-Mar;7(1):61-68. doi: 10.4103/ijmy.ijmy_174_17.
2
Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.UDP-半乳糖变位酶抑制剂的抗分枝杆菌活性。
Int J Antimicrob Agents. 2010 Oct;36(4):364-8. doi: 10.1016/j.ijantimicag.2010.06.030. Epub 2010 Aug 3.
3
Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).UDP-半乳糖吡喃糖变位酶(UGM)候选抑制剂UDP-Galp非离子型底物类似物的合成及生物学评价
Bioorg Med Chem Lett. 2015 May 1;25(9):1995-7. doi: 10.1016/j.bmcl.2015.03.006. Epub 2015 Mar 17.
4
Identification of inhibitors for UDP-galactopyranose mutase.UDP-吡喃半乳糖变位酶抑制剂的鉴定
J Am Chem Soc. 2004 Sep 1;126(34):10532-3. doi: 10.1021/ja048017v.
5
Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.酶促化学合成、抑制研究及 UDP-Galp 膦酸类似物的 X 射线晶体学分析作为 UDP-半乳糖吡喃糖变位酶的抑制剂和作用机制探针。
J Mol Biol. 2010 Nov 5;403(4):578-90. doi: 10.1016/j.jmb.2010.08.053. Epub 2010 Sep 17.
6
Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.结核分枝杆菌 UDP-半乳糖吡喃糖变位酶与配体结合的结构基础:使用底物和全氟化底物类似物。
J Am Chem Soc. 2015 Jan 28;137(3):1230-44. doi: 10.1021/ja511204p. Epub 2015 Jan 16.
7
Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.UDP-吡喃半乳糖变位酶抑制剂可阻止分枝杆菌生长。
J Am Chem Soc. 2008 May 28;130(21):6706-7. doi: 10.1021/ja8018687. Epub 2008 May 1.
8
Conformational Control of UDP-Galactopyranose Mutase Inhibition.UDP-吡喃半乳糖变位酶抑制作用的构象控制
Biochemistry. 2017 Aug 1;56(30):3983-3992. doi: 10.1021/acs.biochem.7b00189. Epub 2017 Jul 20.
9
Identification of inhibitors of UDP-galactopyranose mutase combinatorial screening.UDP-半乳糖吡喃糖变位酶抑制剂的组合筛选鉴定。
Org Biomol Chem. 2021 Mar 4;19(8):1818-1826. doi: 10.1039/d1ob00138h.
10
Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.利用酶亚位点的原核生物UDP-吡喃半乳糖变位酶的强效配体。
Org Lett. 2009 Jan 1;11(1):193-6. doi: 10.1021/ol802094p.

引用本文的文献

1
Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid.杨梅素研究进展:一种天然多功能双黄酮类化合物。
Front Pharmacol. 2021 Dec 22;12:768708. doi: 10.3389/fphar.2021.768708. eCollection 2021.